Logo image of UZE

US CELLULAR CORP - USM 5 1/2 03/01/70 (UZE) Stock Fundamental Analysis

NYSE:UZE - New York Stock Exchange, Inc. - US9116848014 - Currency: USD

21.75  -0.07 (-0.3%)

After market: 21.7 -0.05 (-0.23%)

Fundamental Rating

4

Taking everything into account, UZE scores 4 out of 10 in our fundamental rating. UZE was compared to 21 industry peers in the Wireless Telecommunication Services industry. UZE has an average financial health and profitability rating. UZE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

UZE had positive earnings in the past year.
In the past year UZE had a positive cash flow from operations.
Of the past 5 years UZE 4 years were profitable.
UZE had a positive operating cash flow in each of the past 5 years.
UZE Yearly Net Income VS EBIT VS OCF VS FCFUZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

UZE's Return On Assets of -0.38% is in line compared to the rest of the industry. UZE outperforms 42.86% of its industry peers.
The Return On Equity of UZE (-0.85%) is comparable to the rest of the industry.
UZE's Return On Invested Capital of 1.10% is on the low side compared to the rest of the industry. UZE is outperformed by 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UZE is significantly below the industry average of 6.29%.
The 3 year average ROIC (1.05%) for UZE is below the current ROIC(1.10%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.38%
ROE -0.85%
ROIC 1.1%
ROA(3y)0.13%
ROA(5y)0.85%
ROE(3y)0.32%
ROE(5y)1.91%
ROIC(3y)1.05%
ROIC(5y)1.3%
UZE Yearly ROA, ROE, ROICUZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6

1.3 Margins

Looking at the Operating Margin, with a value of 3.58%, UZE is doing worse than 66.67% of the companies in the same industry.
UZE's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 57.26%, UZE is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
UZE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.58%
PM (TTM) N/A
GM 57.26%
OM growth 3Y-6.02%
OM growth 5Y3.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y0.4%
UZE Yearly Profit, Operating, Gross MarginsUZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), UZE is destroying value.
UZE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for UZE has been reduced compared to 5 years ago.
Compared to 1 year ago, UZE has an improved debt to assets ratio.
UZE Yearly Shares OutstandingUZE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
UZE Yearly Total Debt VS Total AssetsUZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

UZE has an Altman-Z score of 1.04. This is a bad value and indicates that UZE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.04, UZE perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
UZE has a debt to FCF ratio of 8.09. This is a slightly negative value and a sign of low solvency as UZE would need 8.09 years to pay back of all of its debts.
With a Debt to FCF ratio value of 8.09, UZE perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
UZE has a Debt/Equity ratio of 0.62. This is a neutral value indicating UZE is somewhat dependend on debt financing.
The Debt to Equity ratio of UZE (0.62) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.09
Altman-Z 1.04
ROIC/WACC0.15
WACC7.31%
UZE Yearly LT Debt VS Equity VS FCFUZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B

2.3 Liquidity

UZE has a Current Ratio of 1.70. This is a normal value and indicates that UZE is financially healthy and should not expect problems in meeting its short term obligations.
UZE has a better Current ratio (1.70) than 76.19% of its industry peers.
A Quick Ratio of 1.48 indicates that UZE should not have too much problems paying its short term obligations.
UZE's Quick ratio of 1.48 is amongst the best of the industry. UZE outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.48
UZE Yearly Current Assets VS Current LiabilitesUZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

UZE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.46%.
The earnings per share for UZE have been decreasing by -13.19% on average. This is quite bad
The Revenue has decreased by -4.11% in the past year.
UZE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.29% yearly.
EPS 1Y (TTM)7.46%
EPS 3Y-26.25%
EPS 5Y-13.19%
EPS Q2Q%5%
Revenue 1Y (TTM)-4.11%
Revenue growth 3Y-2.93%
Revenue growth 5Y-1.29%
Sales Q2Q%-6.21%

3.2 Future

The Earnings Per Share is expected to grow by 31.56% on average over the next years. This is a very strong growth
UZE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.31% yearly.
EPS Next Y15.94%
EPS Next 2Y25.09%
EPS Next 3Y-3.08%
EPS Next 5Y31.56%
Revenue Next Year-2.92%
Revenue Next 2Y-1.18%
Revenue Next 3Y-0.75%
Revenue Next 5Y-0.31%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UZE Yearly Revenue VS EstimatesUZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
UZE Yearly EPS VS EstimatesUZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 30.21, which means the current valuation is very expensive for UZE.
UZE's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.31, UZE is valued at the same level.
UZE is valuated rather expensively with a Price/Forward Earnings ratio of 19.58.
UZE's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of UZE to the average of the S&P500 Index (22.06), we can say UZE is valued inline with the index average.
Industry RankSector Rank
PE 30.21
Fwd PE 19.58
UZE Price Earnings VS Forward Price EarningsUZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UZE is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
85.71% of the companies in the same industry are more expensive than UZE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.24
EV/EBITDA 5.68
UZE Per share dataUZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
UZE's earnings are expected to decrease with -3.08% in the coming years. This may justify a cheaper valuation.
PEG (NY)1.9
PEG (5Y)N/A
EPS Next 2Y25.09%
EPS Next 3Y-3.08%

5

5. Dividend

5.1 Amount

UZE has a Yearly Dividend Yield of 6.22%, which is a nice return.
Compared to an average industry Dividend Yield of 5.22, UZE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, UZE pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.22%

5.2 History

UZE has been paying a dividend for over 5 years, so it has already some track record.
UZE has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
UZE Yearly Dividends per shareUZE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DP0%
EPS Next 2Y25.09%
EPS Next 3Y-3.08%
UZE Yearly Income VS Free CF VS DividendUZE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

US CELLULAR CORP - USM 5 1/2 03/01/70

NYSE:UZE (6/5/2025, 8:15:17 PM)

After market: 21.7 -0.05 (-0.23%)

21.75

-0.07 (-0.3%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners26.28%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap1.85B
Analysts75.56
Price Target28.48 (30.94%)
Short Float %0.09%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield 6.22%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years2
Ex-Date05-30 2025-05-30 (0.34375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)76.69%
Min EPS beat(2)-39.44%
Max EPS beat(2)192.83%
EPS beat(4)3
Avg EPS beat(4)73.51%
Min EPS beat(4)-39.44%
Max EPS beat(4)192.83%
EPS beat(8)5
Avg EPS beat(8)113.75%
EPS beat(12)6
Avg EPS beat(12)56.53%
EPS beat(16)8
Avg EPS beat(16)47.35%
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-5.4%
Max Revenue beat(2)-0.57%
Revenue beat(4)0
Avg Revenue beat(4)-2.4%
Min Revenue beat(4)-5.4%
Max Revenue beat(4)-0.57%
Revenue beat(8)1
Avg Revenue beat(8)-2.52%
Revenue beat(12)3
Avg Revenue beat(12)-2.02%
Revenue beat(16)3
Avg Revenue beat(16)-2.08%
PT rev (1m)14.58%
PT rev (3m)0.23%
EPS NQ rev (1m)-19.55%
EPS NQ rev (3m)-19.55%
EPS NY rev (1m)-28.09%
EPS NY rev (3m)-25.4%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)-1.94%
Revenue NY rev (3m)-1.15%
Valuation
Industry RankSector Rank
PE 30.21
Fwd PE 19.58
P/S 0.5
P/FCF 5.24
P/OCF 2.2
P/B 0.4
P/tB 462.19
EV/EBITDA 5.68
EPS(TTM)0.72
EY3.31%
EPS(NY)1.11
Fwd EY5.11%
FCF(TTM)4.15
FCFY19.09%
OCF(TTM)9.88
OCFY45.44%
SpS43.66
BVpS53.94
TBVpS0.05
PEG (NY)1.9
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.38%
ROE -0.85%
ROCE 1.39%
ROIC 1.1%
ROICexc 1.12%
ROICexgc 2.19%
OM 3.58%
PM (TTM) N/A
GM 57.26%
FCFM 9.51%
ROA(3y)0.13%
ROA(5y)0.85%
ROE(3y)0.32%
ROE(5y)1.91%
ROIC(3y)1.05%
ROIC(5y)1.3%
ROICexc(3y)1.07%
ROICexc(5y)1.37%
ROICexgc(3y)2.08%
ROICexgc(5y)2.45%
ROCE(3y)1.33%
ROCE(5y)1.64%
ROICexcg growth 3Y-6.62%
ROICexcg growth 5Y1.42%
ROICexc growth 3Y-9.23%
ROICexc growth 5Y-3.33%
OM growth 3Y-6.02%
OM growth 5Y3.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y0.4%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.09
Debt/EBITDA 3.55
Cap/Depr 73.45%
Cap/Sales 13.12%
Interest Coverage 250
Cash Conversion 105.53%
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.48
Altman-Z 1.04
F-Score5
WACC7.31%
ROIC/WACC0.15
Cap/Depr(3y)121.94%
Cap/Depr(5y)166.9%
Cap/Sales(3y)20.71%
Cap/Sales(5y)28.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.46%
EPS 3Y-26.25%
EPS 5Y-13.19%
EPS Q2Q%5%
EPS Next Y15.94%
EPS Next 2Y25.09%
EPS Next 3Y-3.08%
EPS Next 5Y31.56%
Revenue 1Y (TTM)-4.11%
Revenue growth 3Y-2.93%
Revenue growth 5Y-1.29%
Sales Q2Q%-6.21%
Revenue Next Year-2.92%
Revenue Next 2Y-1.18%
Revenue Next 3Y-0.75%
Revenue Next 5Y-0.31%
EBIT growth 1Y-23.56%
EBIT growth 3Y-8.78%
EBIT growth 5Y2.21%
EBIT Next Year19886.2%
EBIT Next 3Y467.35%
EBIT Next 5Y183.49%
FCF growth 1Y406.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.47%
OCF growth 3Y3.26%
OCF growth 5Y4.05%